Equity Bancshares, Inc. (EQBK) serves as the holding company for Equity Bank, a regional bank offering commercial loans, consumer banking, mortgage loans, trust and wealth management, and treasury management services. Based in Wichita, Kansas, it operates in Kansas, Missouri, Oklahoma, Arkansas, Iowa, and now Nebraska. The business revolves around relationship-based community banking, supported by a diversified loan portfolio and deposit base.
In the regional banking space, EQBK stands out through strategic acquisitions that expand its footprint and scale. These recent moves have bolstered fundamentals like net interest margin (NIM)—a critical measure of lending profitability—and asset growth, helping the stock hold up during broader market swings. From what I see, this positioning gives it a solid edge.
In the last 30 days, EQBK stock climbed +6%, moving from $43.70 to close around $46.36. The path was relatively steady, with a brief dip to $42.91 mid-period before consistent gains took hold—this low volatility and upward tilt stand out in my stock price analysis.
Looking at the quarter, the stock managed a +2% gain, from about $45.50 to $46.36. Volatility was more pronounced here: it hit near $49 in January after earnings, dropped to the low $40s in March amid sector pressures, then recovered. This range-bound pattern mirrors trends in regional banks, shaped by interest rate outlooks and overall sentiment.
The +6% rise over 30 days largely came from the benefits of recent acquisitions, like Frontier Holdings (closed January 1, 2026, adding $1.34 billion in loans and $1.1 billion in deposits) and the earlier NBC merger. These have lifted NIM to 4.47% in Q4 2025, driving revenue growth. I also checked this using Tickeron’s AI Screener to compare how EQBK stacks up against industry peers.
Optimism ahead of Q1 2026 earnings on April 14 played a role too, with analysts eyeing EPS of $1.15-$1.21 and revenue of $82-85 million. The dividend increase to $0.18 per share, paid late March, added to its yield attractiveness. Positive short-term technical signals and stable sector conditions—despite shifting rate cut views—supported the steady advance.
That +2% quarterly gain hid some ups and downs, starting with Q4 2025 earnings on January 21, 2026, which spotlighted NIM growth and the Frontier deal's close, pushing shares to $49. Profit-taking followed, along with regional bank challenges like deposit competition and regulatory focus, causing the March pullback.
Steady Federal Reserve rates helped bank margins, while institutional buying countered the dips. M&A-driven asset expansion, with strong loan production, proved resilient. In my view, the net effect of these acquisition gains and solid earnings carried the stock through the fluctuations, in line with market patterns.
In my own research, I often turn to Tickeron’s Trending AI Robots page, which highlights the platform's top-performing AI trading bots out of hundreds available. These bots scan and trade thousands of tickers across markets, using strategies like trend-following, mean reversion, or momentum on timeframes from intraday to long-term. Performance stats—win rate, profit factor, Sharpe ratio—are all laid out clearly, with the selection focused on recent results and market adaptability. It's a practical way to explore automated tools that can sharpen stock analysis and portfolio decisions; I check it regularly to see what's leading now.
I'm watching the Q1 2026 earnings on April 14 closely for insights into acquisition progress, NIM trajectory, and loan growth. Broader regional banking metrics—like deposit betas and net charge-offs (NCOs)—will matter too.
Fed rate moves and inflation figures could shift sentiment, as could further M&A, capital plans, analyst updates (average target $52), and peer results. Risks like slower loan demand in a downturn loom, but strong guidance could lift shares. This is important because it sets the stage for near-term direction.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full Disclaimers and Limitations.
The Moving Average Convergence Divergence (MACD) for EQBK turned positive on June 24, 2026. Looking at past instances where EQBK's MACD turned positive, the stock continued to rise in of 42 cases over the following month. The odds of a continued upward trend are .
The Momentum Indicator moved above the 0 level on June 04, 2026. You may want to consider a long position or call options on EQBK as a result. In of 90 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .
EQBK moved above its 50-day moving average on June 04, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where EQBK advanced for three days, in of 289 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 218 cases where EQBK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for EQBK moved out of overbought territory on June 29, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 41 similar instances where the indicator moved out of overbought territory. In of the 41 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where EQBK declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
EQBK broke above its upper Bollinger Band on June 26, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock slightly better than average.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. EQBK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.240) is normal, around the industry mean (1.302). P/E Ratio (41.619) is within average values for comparable stocks, (17.710). EQBK's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.911). Dividend Yield (0.014) settles around the average of (0.032) among similar stocks. P/S Ratio (4.150) is also within normal values, averaging (3.753).
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a regional bank
Industry RegionalBanks